We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA URGES FDA TO HALT AUTHORIZED GENERICS PRACTICE
GPhA URGES FDA TO HALT AUTHORIZED GENERICS PRACTICE
June 14, 2004
The FDA should issue regulations that would eliminate a brand company’s ability to license an authorized generic product until the first generic applicant’s 180-day exclusivity period has expired, the Generic Pharmaceutical Association (GPhA) has told the agency.